☆ 4.6 Letter

Factor VIIa treatment increases circulating extracellular vesicles in hemophilia patients: Implications for the therapeutic hemostatic effect of FVIIa

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cell Biology

The impact of storage on extracellular vesicles: A systematic study

Stefano Gelibter et al.

Summary: Storage has a significant impact on extracellular vesicles (EVs) samples, leading to a decrease in concentration, reduction in purity, and generation of artefactual particles. It is recommended to process fresh, non-archival samples for EVs analysis, depending on downstream analyses and experimental settings.

JOURNAL OF EXTRACELLULAR VESICLES (2022)

添加到收藏夹

Article Hematology

Factor VIIa suppresses inflammation and barrier disruption through the release of EEVs and transfer of microRNA 10a

Kaushik Das et al.

Summary: This study reveals the interaction mechanism between FVIIa and endothelial cells, as well as the anti-inflammatory and vascular protective effects of FVIIa-released EVs. The results show that FVIIa induces the release of EEVs from endothelial cells through activation of PAR1 and the ROCK-dependent pathway. These EEVs are enriched with anti-inflammatory microRNAs, primarily miR10a. EEVs can be taken up by monocytes/macrophages and endothelial cells, thereby modulating their anti-inflammatory and barrier protective effects.

BLOOD (2022)

添加到收藏夹

Article Hematology

Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect

Kaushik Das et al.

Summary: Studies showed that FVIIa induces the release of EVs from endothelial cells through the EPCR-PAR1 signaling pathway, contributing to the hemostatic effect of FVIIa.

BLOOD (2021)

添加到收藏夹

Article Hematology

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia

Man-Chiu Poon

Summary: The study summarized evidence from three different sources demonstrating the efficacy and safety of rFVIIa in patients with GT without refractoriness or antibodies to platelets, supporting the label extension of rFVIIa as an alternative treatment when platelets are unavailable.

THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation

Fumin Yuan et al.

Summary: Extracellular vesicles (EVs) are nanovesicles released by various cell types, known for their potent biological activities. While -80 degrees C is considered as the most favorable condition for storage, challenges remain in understanding the impact of storage conditions on EVs, indicating further research is needed.

DRUG DELIVERY (2021)

添加到收藏夹

Article Hematology

Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms

Shiva Keshava et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications

Anjana Jeyaram et al.

AAPS JOURNAL (2018)

添加到收藏夹

Review Hematology

Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date

Muriel Giansily-Blaizot et al.

THERAPEUTIC ADVANCES IN HEMATOLOGY (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Methodological Guidelines to Study Extracellular Vesicles

Frank A. W. Coumans et al.

CIRCULATION RESEARCH (2017)

添加到收藏夹

Article Hematology

Monitoring rFVIII prophylaxis dosing using global haemostasis assays

M. A. AL Hawaj et al.

HAEMOPHILIA (2013)

添加到收藏夹

Article Hematology

Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008)

G. Young et al.

HAEMOPHILIA (2012)

添加到收藏夹

Review Hematology

First 20 years with recombinant FVIIa (NovoSeven)

U. Hedner et al.

HAEMOPHILIA (2011)

添加到收藏夹

Article Hematology

Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients

H. Agerso et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)

添加到收藏夹

Review Hematology

Platelet binding and activity of recombinant factor VIIa

Maureane Hoffman et al.

THROMBOSIS RESEARCH (2010)

添加到收藏夹

Article Hematology

FactorVIIa and its potential therapeutic use in bleeding-associated pathologies

Ulla Hedner

THROMBOSIS AND HAEMOSTASIS (2008)

添加到收藏夹

Article Hematology

Experiences with recombinant human factor VIIa in patients with thrombocytopenia

LT Goodnough

SEMINARS IN HEMATOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.